Clinical Trials Directory

Trials / Unknown

UnknownNCT03719222

Analysis of Tumor Mutations and Tumor Microenvironment Using Archival Paraffin-embedded Tumor Specimens

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
ACT Genomics · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Genomic alterations have long been recognized as an important factor in tumor formation and drive tumor cell growth. However, the degree of genomic mutation (tumor mutation load, TMB) varies widely between tumors. In addition to gene mutations in tumor cells, the extent of immune cell infiltration in tumor tissues and the type and nature of immune cells (tumor microenvironment, TME) also play an important role in controlling tumor growth. In recent years, more and more clinical studies have shown that the degree of genomic alteration (TMB) and tumor microenvironment (TME) have great potential in predicting a cancer patients' response to immunotherapy. Therefore, understanding the interaction and correlation between genomic alteration and tumor immune environment will not only deepen our understanding of tumor biology but also provide an important reference for developing immunotherapy treatment strategies for solid tumors.

Detailed description

This is a non-interventional, mono-centric retrospective study to be carried out in Chi Mei Medical Center (CMMC) in order to determine the association between the genomic alterations and gene expression level of immune-related genes in cancer. Samples in paraffin-embedded block of biopsies or surgical pieces (either primary tumor or metastases) will be analyzed. For each sample, clinically relevant data associated with treated cancer and needed for characterization of tumor microenvironment will be documented. No additional procedures besides those already used in the routine clinical practice will be applied to the patients. Treatment assignment will be done according to the current practice. This trial is, through accessing to archival tumor materials, to establish the relationship between tumor mutation burden and tumor immune microenvironment for future immunotherapy strategy.

Conditions

Interventions

TypeNameDescription
OTHERnon interventionIt is an non-interventional retrospective observational study by using archived paraffin-embedded tumor specimens

Timeline

Start date
2018-09-26
Primary completion
2019-09-01
Completion
2019-09-01
First posted
2018-10-25
Last updated
2018-10-29

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03719222. Inclusion in this directory is not an endorsement.